Agios Pharmaceuticals
AGIO
#5134
Rank
NZ$3.01 B
Marketcap
NZ$50.45
Share price
-4.03%
Change (1 day)
12.24%
Change (1 year)

EPS for Agios Pharmaceuticals (AGIO)

EPS in 2026 (TTM): NZ-$10.92

According to Agios Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is NZ-$11.42. In 2021 the company made an earnings per share (EPS) of NZ$40.65 an increase over its 2020 EPS that were of NZ-$8.66.

EPS history for Agios Pharmaceuticals from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$10.92
2021NZ$40.65-569.2%
2020NZ-$8.66-31%
2019NZ-$12.5613.93%
2018NZ-$11.02-10.53%
2017NZ-$12.3233.47%
2016NZ-$9.2361.34%
2015NZ-$5.7298.1%
2014NZ-$2.89-4.34%
2013NZ-$3.02

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
NZ$1.30-111.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$56.47-594.25%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$5.26-146.04%๐Ÿ‡ฌ๐Ÿ‡ง UK
Xencor
XNCR
NZ-$2.87-74.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
NZ$6.32-155.36%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ-$0.16-98.56%๐Ÿ‡บ๐Ÿ‡ธ USA